Login / Signup

Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy.

Violetta RitterFranziska KrautterDiana KleinVerena JendrossekJustine Rudner
Published in: Cell death & disease (2022)
Keyphrases
  • early stage
  • radiation therapy
  • locally advanced
  • endothelial cells
  • radiation induced
  • squamous cell carcinoma
  • rectal cancer